1
|
Douglas KO, Payne K, Sabino-Santos G, Agard J. Influence of Climatic Factors on Human Hantavirus Infections in Latin America and the Caribbean: A Systematic Review. Pathogens 2021; 11:pathogens11010015. [PMID: 35055965 PMCID: PMC8778283 DOI: 10.3390/pathogens11010015] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2021] [Revised: 12/16/2021] [Accepted: 12/17/2021] [Indexed: 01/18/2023] Open
Abstract
BACKGROUND With the current climate change crisis and its influence on infectious disease transmission there is an increased desire to understand its impact on infectious diseases globally. Hantaviruses are found worldwide, causing infectious diseases such as haemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS)/hantavirus pulmonary syndrome (HPS) in tropical regions such as Latin America and the Caribbean (LAC). These regions are inherently vulnerable to climate change impacts, infectious disease outbreaks and natural disasters. Hantaviruses are zoonotic viruses present in multiple rodent hosts resident in Neotropical ecosystems within LAC and are involved in hantavirus transmission. METHODS We conducted a systematic review to assess the association of climatic factors with human hantavirus infections in the LAC region. Literature searches were conducted on MEDLINE and Web of Science databases for published studies according to Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) criteria. The inclusion criteria included at least eight human hantavirus cases, at least one climatic factor and study from > 1 LAC geographical location. RESULTS In total, 383 papers were identified within the search criteria, but 13 studies met the inclusion criteria ranging from Brazil, Chile, Argentina, Bolivia and Panama in Latin America and a single study from Barbados in the Caribbean. Multiple mathematical models were utilized in the selected studies with varying power to generate robust risk and case estimates of human hantavirus infections linked to climatic factors. Strong evidence of hantavirus disease association with precipitation and habitat type factors were observed, but mixed evidence was observed for temperature and humidity. CONCLUSIONS The interaction of climate and hantavirus diseases in LAC is likely complex due to the unknown identity of all vertebrate host reservoirs, circulation of multiple hantavirus strains, agricultural practices, climatic changes and challenged public health systems. There is an increasing need for more detailed systematic research on the influence of climate and other co-related social, abiotic, and biotic factors on infectious diseases in LAC to understand the complexity of vector-borne disease transmission in the Neotropics.
Collapse
Affiliation(s)
- Kirk Osmond Douglas
- Centre for Biosecurity Studies, Cave Hill Campus, The University of the West Indies, Cave Hill, St. Michael BB11000, Barbados
- Correspondence:
| | - Karl Payne
- Centre for Resource Management and Environmental Studies, Cave Hill Campus, The University of the West Indies, Cave Hill, St. Michael BB11000, Barbados;
| | - Gilberto Sabino-Santos
- School of Public Health and Tropical Medicine, Tulane University, 1324 Tulane Ave Suite 517, New Orleans, LA 70112, USA;
- Centre for Virology Research, Ribeirao Preto Medical School, University of Sao Paulo, 3900 Av. Bandeirantes, Ribeirao Preto 14049-900, SP, Brazil
| | - John Agard
- Department of Life Sciences, The University of the West Indies, St. Augustine 999183, Trinidad and Tobago;
| |
Collapse
|
2
|
Hesse S, Nuñez H, Salazar JR, Salinas TP, Barrera E, Chong R, Torres S, Cumbrera A, Olivares I, Junco A, Matteo C, González C, Chavarría O, Moreno A, Góndola J, Ábrego L, Díaz Y, Pitti Y, Franco D, Martínez-Montero M, Pascale JM, López-Vergès S, Martínez AA, Armién B. Case Report: First Confirmed Case of Coinfection of SARS-CoV-2 With Choclo orthohantavirus. FRONTIERS IN TROPICAL DISEASES 2021; 2:769330. [PMID: 34851327 PMCID: PMC8594034 DOI: 10.3389/fitd.2021.769330] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2021] [Accepted: 10/19/2021] [Indexed: 11/26/2022] Open
Abstract
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a major international public health concern. The World Health Organization (WHO) declared the pandemic of coronavirus disease 2019 (COVID-19) on March 11, 2020. In Panama, the first SARS-CoV-2 infection was confirmed on March 9, 2020, and the first fatal case associated to COVID-19 was reported on March 10. This report presents the case of a 44-year-old female who arrived at the hospital with a respiratory failure, five days after the first fatal COVID-19 case, and who was living in a region where hantavirus pulmonary syndrome cases caused by Choclo orthohantavirus (CHOV), are prevalent. Thus, the clinical personnel set a differential diagnosis to determine a respiratory disease caused by the endemic CHOV or the new pandemic SARS-CoV-2. This case investigation describes the first coinfection by SARS-CoV-2 and CHOV worldwide. PCR detected both viruses during early stages of the disease and the genomic sequences were obtained. The presence of antibodies was determined during the patient’s hospitalization. After 23 days at the intensive care unit, the patient survived with no sequelae, and antibodies against CHOV and SARS-CoV-2 were still detectable 12 months after the disease. The detection of the coinfection in this patient highlights the importance, during a pandemic, of complementing the testing and diagnosis of the emergent agent, SARS-CoV-2, with other common endemic respiratory pathogens and other zoonotic pathogens, like CHOV, in regions where they are of public health concern.
Collapse
Affiliation(s)
- Susana Hesse
- Intensive Care Unit, Luis "Chicho" Fabrega Hospital, Ministry of Health, Santiago, Panama
| | - Heydy Nuñez
- Department of Epidemiology, National Social Security Fund, Santiago, Panama.,Department of Epidemiology, Ezequiel Abadia Hospital, Soná, Panama
| | - Jacqueline R Salazar
- Department of Research in Emerging and Zoonotic Infectious Diseases, Gorgas Memorial Institute for Health Studies, Panama City, Panama
| | - Tybbysay P Salinas
- Department of Research in Emerging and Zoonotic Infectious Diseases, Gorgas Memorial Institute for Health Studies, Panama City, Panama
| | - Erika Barrera
- Intensive Care Unit, Luis "Chicho" Fabrega Hospital, Ministry of Health, Santiago, Panama
| | - Ricardo Chong
- Regional Department of Epidemiology, Ministry of Health, Santiago, Panama
| | - Saúl Torres
- Department of Epidemiology, Ezequiel Abadia Hospital, Soná, Panama
| | - Amarellys Cumbrera
- Intensive Care Unit, Luis "Chicho" Fabrega Hospital, Ministry of Health, Santiago, Panama
| | - Idiamín Olivares
- Intensive Care Unit, Luis "Chicho" Fabrega Hospital, Ministry of Health, Santiago, Panama
| | - Aimee Junco
- Intensive Care Unit, Luis "Chicho" Fabrega Hospital, Ministry of Health, Santiago, Panama
| | - Christian Matteo
- Intensive Care Unit, Luis "Chicho" Fabrega Hospital, Ministry of Health, Santiago, Panama
| | - Claudia González
- Department of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama
| | - Oris Chavarría
- Department of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama
| | - Ambar Moreno
- Department of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama
| | - Jessica Góndola
- Department of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama
| | - Leyda Ábrego
- Department of Research in Virology and Biotechnology, Gorgas Memorial Institute for Health Studies, Panama City, Panama.,National Research System (SNI), National Secretary of Research, Technology and Innovation (SENACYT), Panama City, Panama
| | - Yamilka Díaz
- Department of Research in Virology and Biotechnology, Gorgas Memorial Institute for Health Studies, Panama City, Panama
| | - Yaneth Pitti
- Department of Research in Virology and Biotechnology, Gorgas Memorial Institute for Health Studies, Panama City, Panama
| | - Danilo Franco
- Department of Research in Virology and Biotechnology, Gorgas Memorial Institute for Health Studies, Panama City, Panama
| | - Mabel Martínez-Montero
- Inmunovirology Section, Central Reference Laboratory in Public Health, Gorgas Memorial Institute for Health Studies, Panama City, Panama
| | - Juan Miguel Pascale
- Department of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama.,National Research System (SNI), National Secretary of Research, Technology and Innovation (SENACYT), Panama City, Panama
| | - Sandra López-Vergès
- Department of Research in Virology and Biotechnology, Gorgas Memorial Institute for Health Studies, Panama City, Panama.,National Research System (SNI), National Secretary of Research, Technology and Innovation (SENACYT), Panama City, Panama
| | - Alexander A Martínez
- Department of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama.,National Research System (SNI), National Secretary of Research, Technology and Innovation (SENACYT), Panama City, Panama
| | - Blas Armién
- Department of Research in Emerging and Zoonotic Infectious Diseases, Gorgas Memorial Institute for Health Studies, Panama City, Panama.,National Research System (SNI), National Secretary of Research, Technology and Innovation (SENACYT), Panama City, Panama
| |
Collapse
|
3
|
Kalaiselvan S, Sankar S, Ramamurthy M, Ghosh AR, Nandagopal B, Sridharan G. Prediction of Pan-Specific B-Cell Epitopes From Nucleocapsid Protein of Hantaviruses Causing Hantavirus Cardiopulmonary Syndrome. J Cell Biochem 2017; 118:2320-2324. [PMID: 28106282 DOI: 10.1002/jcb.25887] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2016] [Accepted: 01/18/2017] [Indexed: 02/04/2023]
Abstract
Hantaviruses are emerging viral pathogens that causes hantavirus cardiopulmonary syndrome (HCPS) in the Americas, a severe, sometimes fatal, respiratory disease in humans with a case fatality rate of ≥50%. IgM and IgG-based serological detection methods are the most common approaches used for laboratory diagnosis of hantaviruses. Such emerging viral pathogens emphasizes the need for improved rapid diagnostic devices and vaccines incorporating pan-specific epitopes of genotypes. We predicted linear B-cell epitopes for hantaviruses that are specific to genotypes causing HCPS in humans using in silico prediction servers. We modeled the Andes and Sin Nombre hantavirus nucleocapsid protein to locate the identified epitopes. Based on the mean percent prediction probability score, epitope IMASKSVGS/TAEEKLKKKSAF was identified as the best candidate B-cell epitope specific for hantaviruses causing HCPS. Promiscuous epitopes were identified in the C-terminal of the protein. Our study for the first time has reported pan-specific B-cell epitopes for developing immunoassays in the detection of antibodies to hantaviruses causing HCPS. Identification of epitopes with pan-specific recognition of all genotypes causing HCPS could be valuable for the development of immunodiagnositic tools toward pan-detection of hantavirus antibodies in ELISA. J. Cell. Biochem. 118: 2320-2324, 2017. © 2017 Wiley Periodicals, Inc.
Collapse
Affiliation(s)
- Sagadevan Kalaiselvan
- Sri Sakthi Amma Institute of Biomedical Research, Sri Narayani Hospital and Research Centre, Sripuram, Vellore 632 055, Tamil Nadu, India
| | - Sathish Sankar
- Sri Sakthi Amma Institute of Biomedical Research, Sri Narayani Hospital and Research Centre, Sripuram, Vellore 632 055, Tamil Nadu, India
| | - Mageshbabu Ramamurthy
- Sri Sakthi Amma Institute of Biomedical Research, Sri Narayani Hospital and Research Centre, Sripuram, Vellore 632 055, Tamil Nadu, India
| | - Asit Ranjan Ghosh
- Centre for Infectious Diseases and Control, School of Biosciences and Technology, VIT University, Vellore 632014, Tamil Nadu, India
| | - Balaji Nandagopal
- Sri Sakthi Amma Institute of Biomedical Research, Sri Narayani Hospital and Research Centre, Sripuram, Vellore 632 055, Tamil Nadu, India
| | - Gopalan Sridharan
- Sri Sakthi Amma Institute of Biomedical Research, Sri Narayani Hospital and Research Centre, Sripuram, Vellore 632 055, Tamil Nadu, India
| |
Collapse
|